Company: MDCXW
Filing Date: 2025-12-10
Form Type: DRS
Source: 0001062993-25-017281
Chunk: 51

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-10
Form: DRS
Chunk 51
---
, 2025 (incorporated by reference from Exhibit 10.1 to the Registrant's Current Report on Form 8-K, filed with the SEC on September 18, 2025).                                                                                                 |
| 10.14   | Global Guaranty Agreement, by and among the subsidiaries of Medicus Pharma Ltd. set forth in Schedule I thereto, dated September 17, 2025 (incorporated by reference from Exhibit 10.2 to the Registrant's Current Report on Form 8-K, filed with the SEC on September 18, 2025).                                                                      |
| 10.15   | Form of Warrant Inducement Agreement (incorporated by reference from Exhibit 10.1 to the Registrant's Current Report on Form 8-K, filed with the SEC on December 8, 2025)                                                                                                                                                                              |
| 23.1α   | Consent of EisnerAmper LLP                                                                                                                                                                                                                                                                                                                             |
| 23.2α   | Consent of MNP LLP                                                                                                                                                                                                                                                                                                                                     |
| 23.3α   | Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                                                                                                                 |

<div align='center'>II-5

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.PURSUANT TO 17 C.F.R. SECTION 200.83</div>

| Exhibit 
 No.     | Description                                                                        |
| 23.4α   | Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.2)  |
| 24.1α   | Powers of Attorney (included in the signature page to this Registration Statement) |
| 107α    | Filing fee table                                                                   |

αTo be filed by amendment.

+Indicates a management contract or compensatory plan.

&To be filed with a Current Report on Form 8-K or a Post-Effective Amendment to the registration statement.

*Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

†Certain private